![Kathy Connell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 14 340 $ al 31/08/2026
Kathy Connell is the founder of Medicines Australia.
Current jobs include Non-Executive Director at Avecho Biotechnology Ltd. starting in 2024, Independent Non-Executive Director at Ceryvyn Therapeutics Ltd. starting in 2024, and Non-Executive Director at Proto Axiom Pty Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/06/2026 | 2.000.000 ( 0,15 % ) | 14 340 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AVECHO BIOTECHNOLOGY LIMITED | Director/Miembro de la Junta | 26/04/2024 |
| CERYVYN THERAPEUTICS LIMITED | Director/Miembro de la Junta | 15/11/2024 |
Proto Axiom Pty Ltd.
 Proto Axiom Pty Ltd. BiotechnologyHealth Technology Engages in drug development and medical equipment | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Medicines Australia
 Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Avecho Biotechnology Ltd.
 Avecho Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical and nutraceutical products | Health Technology |
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
Proto Axiom Pty Ltd.
Proto Axiom Pty Ltd. BiotechnologyHealth Technology Engages in drug development and medical equipment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
